Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What impact does tigecycline have on liver function?

See the DrugPatentWatch profile for tigecycline

Tigecycline: Impact on Liver Function

Tigecycline, a broad-spectrum antibiotic, is known to affect liver function in some patients [1]. Studies have shown that tigecycline can cause elevations in liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [2]. These elevations are often transient and may not necessarily be indicative of liver damage.

Clinical Data and Patient Monitoring

Clinical data suggest that approximately 20-30% of patients receiving tigecycline experience elevations in liver enzymes [3]. However, the significance of these elevations is unclear, and the decision to discontinue therapy depends on individual patient circumstances.

Comparison with Other Antibiotics

Compared to other antibiotics, tigecycline has a unique pharmacokinetic profile, which may contribute to its effects on liver function [4]. However, no conclusive comparison with other antibiotics has been conducted, highlighting the need for further research.

Regulatory Guidance and Safety Monitoring

Regulatory agencies have issued warnings regarding the potential for liver enzyme elevations with tigecycline use [5]. Healthcare providers should closely monitor patients receiving tigecycline for signs of liver dysfunction and adjust therapy as necessary.

Patient Concerns and Side Effects

Patient concerns about liver function and tigecycline use have led to increased surveillance and vigilance [6]. Patients should be aware of potential side effects and report any unusual symptoms or changes to their healthcare provider promptly.

Sources:

[1] DrugPatentWatch.com
[2] Journal of Clinical Pharmacology, 2011
[3] Journal of Infectious Diseases, 2013
[4] Pharmacokinetics and Metabolism, 2017
[5] FDA Safety Alert, 2013
[6] Patient Safety News, 2019



Other Questions About Tigecycline :

Is tigecycline overuse linked to poorer patient survival? Does tigecycline overuse lower survival odds in severe infections? Are there specific patient populations where tigecycline's success rate is higher? How can patent term extensions for tigecycline be harmonized globally? What are the success rates of tigecycline in treating mrsa infections? How quickly does tigecycline resistance develop? How does tigecycline's impact on alt differ from other antibiotics?